Literature DB >> 26724948

Reliability and validity of the Chinese version of the questionnaire of olfactory disorders (QOD) when used with patients having olfactory dysfunction.

DaHai Yang1, Jian Wang2, DaoFeng Ni1, JianFeng Liu3, Xin Wang1.   

Abstract

To cross-culturally adapt the Questionnaire of olfactory disorders (QOD) into a Chinese version, and then evaluate its reliability and validity for testing patients with olfactory dysfunction. A Chinese version of the QOD was evaluated for test-retest reliability, split-half reliability, and internal consistency. The validity analysis included components of content validity and criterion-related validity, as well as comparisons between The Medical Outcomes Study's36-Item ShortForm Health Survey(SF-36)questionnaire and the WHO Quality of Life-BREF (WHOQOL-BREF)questionnaire. A total of 125 patients with olfactory dysfunction were tested, and 104 patients completed three different surveys (QOD, SF-36, and WHOQOL-BREF). The test-retest reliabilities of the QOD-Parosmia statements (QOD-P), QOD-Quality of life (QOD-QoL), and QOD-Visual simulation (QOD-VAS)sections were 0.802 (P < 0.001), 0.797 (P < 0.001), and 0.468 (P < 0.001), respectively, and the Cronbach's α coefficients of internal consistency were 0.473, 0.814, and 0.882, respectively. The split-half reliability was 0.70. No correlation was found between the QOD-P section and the SF-36; however, there were statistically significant correlations between the QOD-QoL andQOD-VAS sections and the SF-36. The same results were observed for correlations between the QOD and WHOQOL-BREF. The Chinese version of the QOD was proven to be a generally reliable and valid questionnaire for use in evaluating mainland Chinese patients suspected of having olfactory dysfunction. However, the QOD-P section requires further modifications to properly evaluate patients with a Chinese cultural background and type of cognition.

Entities:  

Keywords:  Olfactory dysfunction; Questionnaire of olfactory disorders; Reliability; Validity

Mesh:

Year:  2016        PMID: 26724948     DOI: 10.1007/s00405-015-3869-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  20 in total

1.  Evaluating the clinical usefulness of structured questions in parosmia assessment.

Authors:  Basile N Landis; Johannes Frasnelli; Ilona Croy; Thomas Hummel
Journal:  Laryngoscope       Date:  2010-08       Impact factor: 3.325

2.  A computerized adaptive version of the SF-36 is feasible for clinic and Internet administration in adults with HIV.

Authors:  Diane M Turner-Bowker; Renee N Saris-Baglama; Michael A DeRosa; Erin R Giovannetti; Roxanne E Jensen; Albert W Wu
Journal:  AIDS Care       Date:  2012-02-21

3.  Olfactory dysfunction and asthma as risk factors for poor quality of life in upper airway diseases.

Authors:  Michael Katotomichelakis; Efthimios Simopoulos; Nan Zhang; Gregory Tripsianis; Gerasimos Danielides; Miltos Livaditis; Claus Bachert; Vassilios Danielides
Journal:  Am J Rhinol Allergy       Date:  2013 Jul-Aug       Impact factor: 2.467

4.  Health-related and specific olfaction-related quality of life in patients with chronic functional anosmia or severe hyposmia.

Authors:  Claudia Neuland; Thomas Bitter; Heike Marschner; Hilmar Gudziol; Orlando Guntinas-Lichius
Journal:  Laryngoscope       Date:  2011-02-04       Impact factor: 3.325

5.  Olfactory deficits induce neurofilament hyperphosphorylation.

Authors:  Juan Hu; Xiang Wang; Dan Liu; Qun Wang; Ling-Qiang Zhu
Journal:  Neurosci Lett       Date:  2011-11-06       Impact factor: 3.046

6.  [Correlations between olfactory and cognitive functions in early stage Parkinson's disease].

Authors:  Shasha Guo; Ling Li; Yan Dai; Qing Tang; Yi Chen; Sijiao Li; Jing Chen; Chengjie Mao; Jie Li; Chunfeng Liu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2015-02-17

7.  Sense of smell disorder and health-related quality of life.

Authors:  Monique A M Smeets; Maria G Veldhuizen; Sara Galle; Juul Gouweloos; Anne-Marie J A de Haan; Jesse Vernooij; Floris Visscher; Jan H A Kroeze
Journal:  Rehabil Psychol       Date:  2009-11

8.  [Application of unilateral olfactory testing and clinical analysis of unilateral hyposmia].

Authors:  Jing Guan; Dao-feng Ni; Jian Wang; Jian-feng Liu; Ying-ying Zhu
Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2012-11

Review 9.  Hyposmia: a possible biomarker of Parkinson's disease.

Authors:  Qian Xiao; Sheng Chen; Weidong Le
Journal:  Neurosci Bull       Date:  2013-10-17       Impact factor: 5.203

10.  A simple visual analog scale for pain is as responsive as the WOMAC, the SF-36, and the EQ-5D in measuring outcomes of revision hip arthroplasty.

Authors:  Vasilis Zampelis; Ewald Ornstein; Herbert Franzén; Isam Atroshi
Journal:  Acta Orthop       Date:  2014-01-30       Impact factor: 3.717

View more
  3 in total

1.  MR Imaging-Based Evaluations of Olfactory Bulb Atrophy in Patients with Olfactory Dysfunction.

Authors:  M S Chung; W R Choi; H-Y Jeong; J H Lee; J H Kim
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-21       Impact factor: 3.825

2.  Is the Persian Version of the "Olfactory Disorder Questionnaire" Reliable and Valid?

Authors:  Maryam Jalessi; Seyed Kamran Kamrava; Elahe Amini; Farhad Rafiei; Mohammad Amin Nasouti; Naeimeh Moosavi; Mohammad Farhadi
Journal:  Iran J Otorhinolaryngol       Date:  2017-07

3.  Predictive significance of the questionnaire of olfactory disorders-negative statements for olfactory loss in patients with chronic rhinosinusitis.

Authors:  Dawei Wu; Yongxiang Wei; Fan Yuan
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-19       Impact factor: 3.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.